FDA’s Classification of Plazomicin Test System: Ensuring Safety and Innovation

Discover how the FDA’s classification of the plazomicin test system into class II (special controls) ensures safety and effectiveness while enhancing patient access to innovative medical technologies. This course details the specific requirements and benefits of the classification, providing crucial insights for professionals navigating the regulatory landscape.

In this course you will learn the following:
* Understand the classification process and criteria for the plazomicin test system.
* Identify the special controls required for compliance with the new classification.
* Recognize the benefits of the De Novo classification process in reducing regulatory burdens.